Article
Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial.
International journal of radiation oncology, biology, physics - 1 Sept 2007
Roach Mack, De Silvio Michelle, Rebbick Timothy, Grignon David, Rotman Marvin, Wolkov Harvey, Fisher Barbara, Hanks Gerald, Shipley William U, Pollack Alan, Sandler Howard, Watkins-Bruner Deborah
Abstract excerpt
PURPOSE: Inherited genotypes may explain the inferior outcomes of African American (AA) men with prostate cancer. To understand how variation in CYP3A4 correlated with outcomes, a retrospective examination of the CYP3A4 *1B genotype was performed on men treated with Radiation Therapy Oncology Group (RTOG) 92-02. METHODS AND MATERIALS: From 1,514 cases, we evaluated 56 (28.4%) of 197 AA and 54 (4.3%) of 1,274...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
